These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29410469)

  • 1. Quantitative Magnetization Transfer in Monitoring Glioblastoma (GBM) Response to Therapy.
    Mehrabian H; Myrehaug S; Soliman H; Sahgal A; Stanisz GJ
    Sci Rep; 2018 Feb; 8(1):2475. PubMed ID: 29410469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma (GBM) effects on quantitative MRI of contralateral normal appearing white matter.
    Mehrabian H; Lam WW; Myrehaug S; Sahgal A; Stanisz GJ
    J Neurooncol; 2018 Aug; 139(1):97-106. PubMed ID: 29594656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Glioblastoma Response to Therapy With Chemical Exchange Saturation Transfer.
    Mehrabian H; Myrehaug S; Soliman H; Sahgal A; Stanisz GJ
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):713-723. PubMed ID: 29893279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of Primary Brain Tumors and Metastases with Fast Quantitative 3-Dimensional Magnetization Transfer.
    Garcia M; Gloor M; Bieri O; Radue EW; Lieb JM; Cordier D; Stippich C
    J Neuroimaging; 2015; 25(6):1007-14. PubMed ID: 25702714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentric non-enhancing lesions in glioblastoma: A retrospective study.
    Benouaich-Amiel A; Khasminsky V; Gal O; Weiss T; Fichman S; Kanner AA; Berkowitz S; Laviv Y; Mandel J; Dudnik E; Siegal T; Yust-Katz S
    J Clin Neurosci; 2021 Mar; 85():20-26. PubMed ID: 33581785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility and Tumor Size Changes During the Time Course of Standard Treatment in Recurrent Glioblastoma.
    van Leyen K; Roelcke U; Gruber P; Remonda L; Berberat J
    J Neuroimaging; 2019 Sep; 29(5):645-649. PubMed ID: 31112344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme.
    Gainer JL; Sheehan JP; Larner JM; Jones DR
    J Neurosurg; 2017 Feb; 126(2):460-466. PubMed ID: 27177177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report.
    Hsu BH; Lee WH; Yang ST; Han CT; Tseng YY
    BMC Neurol; 2020 May; 20(1):178. PubMed ID: 32393192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
    Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
    J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological tumor volume in 18FET-PET before radiochemotherapy correlates with survival in GBM.
    Suchorska B; Jansen NL; Linn J; Kretzschmar H; Janssen H; Eigenbrod S; Simon M; Pöpperl G; Kreth FW; la Fougere C; Weller M; Tonn JC;
    Neurology; 2015 Feb; 84(7):710-9. PubMed ID: 25609769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pool size ratio of the substantia nigra in Parkinson's disease derived from two different quantitative magnetization transfer approaches.
    Trujillo P; Summers PE; Smith AK; Smith SA; Mainardi LT; Cerutti S; Claassen DO; Costa A
    Neuroradiology; 2017 Dec; 59(12):1251-1263. PubMed ID: 28986653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation.
    Chan RW; Chen H; Myrehaug S; Atenafu EG; Stanisz GJ; Stewart J; Maralani PJ; Chan AKM; Daghighi S; Ruschin M; Das S; Perry J; Czarnota GJ; Sahgal A; Lau AZ
    J Neurooncol; 2021 Jan; 151(2):267-278. PubMed ID: 33196965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the Prebolus T1 Measurement and the Fixed T1 Value in Dynamic Contrast-Enhanced MR Imaging for the Differentiation of True Progression from Pseudoprogression in Glioblastoma Treated with Concurrent Radiation Therapy and Temozolomide Chemotherapy.
    Nam JG; Kang KM; Choi SH; Lim WH; Yoo RE; Kim JH; Yun TJ; Sohn CH
    AJNR Am J Neuroradiol; 2017 Dec; 38(12):2243-2250. PubMed ID: 29074633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme.
    Baumann F; Bjeljac M; Kollias SS; Baumert BG; Brandner S; Rousson V; Yonekawa Y; Bernays RL
    J Neurooncol; 2004; 67(1-2):191-200. PubMed ID: 15072467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral aspergillosis within new tumour site presents as incidental new brain lesion in patient receiving temozolomide for glioblastoma multiforme.
    Liu SA; Sullivan T; Bryce C; Chan AM; Cilmi S
    BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31154345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist.
    Wang H; Cai S; Bailey BJ; Reza Saadatzadeh M; Ding J; Tonsing-Carter E; Georgiadis TM; Zachary Gunter T; Long EC; Minto RE; Gordon KR; Sen SE; Cai W; Eitel JA; Waning DL; Bringman LR; Wells CD; Murray ME; Sarkaria JN; Gelbert LM; Jones DR; Cohen-Gadol AA; Mayo LD; Shannon HE; Pollok KE
    J Neurosurg; 2017 Feb; 126(2):446-459. PubMed ID: 27177180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypofractionated versus standard radiation therapy in combination with temozolomide for glioblastoma in the elderly: a meta-analysis.
    Lu VM; Kerezoudis P; Brown DA; Burns TC; Quinones-Hinojosa A; Chaichana KL
    J Neurooncol; 2019 Jun; 143(2):177-185. PubMed ID: 30919157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction.
    Kim BR; Choi SH; Yun TJ; Lee ST; Park CK; Kim TM; Kim JH; Park SW; Sohn CH; Park SH; Kim IH
    PLoS One; 2016; 11(11):e0166096. PubMed ID: 27835666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, Radiographic, and Pathologic Findings in Patients Undergoing Reoperation Following Radiation Therapy and Temozolomide for Newly Diagnosed Glioblastoma.
    Ellsworth S; Ye X; Grossman SA
    Am J Clin Oncol; 2017 Jun; 40(3):219-222. PubMed ID: 26491903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma management in the temozolomide era: have we improved outcome?
    Lwin Z; MacFadden D; Al-Zahrani A; Atenafu E; Miller BA; Sahgal A; Menard C; Laperriere N; Mason WP
    J Neurooncol; 2013 Nov; 115(2):303-10. PubMed ID: 23979682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.